NDC product
DigiFab
NDC 87131-120 · Salvagenix Inc.
Key facts
| Product NDC | 87131-120 |
|---|---|
| Proprietary name | DigiFab |
| Nonproprietary name | ovine digoxin immune fab |
| Substances | OVINE DIGOXIN IMMUNE FAB |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Labeler | Salvagenix Inc. |
| Product type | PLASMA DERIVATIVE |
| Marketing category | BLA |
| Application number | BLA103910 |
| Pharmacologic classes | Cardiac Glycoside [EPC], Cardiac Glycosides [CS] |
| Marketing start | Mar 20, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: